Joint Formulary & PAD

Tiotropium with olodaterol (Spiolto Respimat) - Chronic Obstructive Pulmonary Disease (COPD)

You are here : Home > Formulary Search > Tiotropium with olodaterol (Spiolto Respimat) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Soft mist inhaler
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :

Documentation

Guidelines (Local)
COPD Primary Care Medicines Management Guidelines - updated Jun 23
Webpage
How to use a Respimat inhaler - video
Patient resource
How to use a Respimat inhaler - Patient information leaflet

PAD Profile

ChemicalSubstance :
Tiotropium with olodaterol (Spiolto Respimat)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA LABA
Keywords :
LAMA LABA, LAMA/LABAs, LABA/LAMAs, antimuscarinic bronchodilators, respiratory
Brand Names Include :
Spiolto Respimat
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Chronic Obstructive Pulmonary Disease (COPD)
Supporting Documents :
3

Committee Recommendations (1)

04 Mar 20 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The locally preferred LAMA/LABA devices are as follows:

  • Spiolto Respimat (tiotropium / olodaterol soft mist inhaler). Re-usable device.
  • Anoro Ellipta (Umeclidinium / vilanterol DPI)
  • Ultibro Breezhaler (Glycopyrronium / indacaterol DPI)
  • Duaklir Genuair (Aclidinium / formoterol DPI)

Devices should be prescribed by BRAND

See full COPD guidelines for more information

Other Indications

Below are listed other indications that Tiotropium with olodaterol (Spiolto Respimat) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).